
VolitionRx Limited VNRX
€ 0.17
0.7%
Quartalsbericht 2025-Q3
hinzugefügt 13.11.2025
VolitionRx Limited EV 2011-2026 | VNRX
EV Jährlich VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87 M | 74.1 M | 99.7 M | 146 M | 181 M | 175 M | 71.6 M | 87.2 M | 88.8 M | 62.6 M | 68.1 M | 27.6 M | 24.4 M | -218 K |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 181 M | -218 K | 85.2 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Bioventus
BVS
|
1.01 B | $ 9.0 | 1.47 % | $ 600 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 13.99 | 2.49 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 26.24 | 1.59 % | $ 729 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 154.17 | 1.45 % | $ 7.64 B | ||
|
DexCom
DXCM
|
28.2 B | $ 68.54 | 3.32 % | $ 26.7 B | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 17.77 | 2.6 % | $ 947 M | ||
|
Guardant Health
GH
|
15.2 B | $ 88.16 | 1.12 % | $ 11.1 B | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | $ 103.95 | 0.1 % | $ 19.6 B | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.57 | 4.15 % | $ 471 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
142 M | $ 17.22 | -0.4 % | $ 2.23 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 101.08 | 3.55 % | $ 8.34 B | ||
|
Anixa Biosciences
ANIX
|
990 K | $ 2.88 | 1.23 % | $ 93.5 K | ||
|
IQVIA Holdings
IQV
|
49.6 B | $ 169.85 | 3.01 % | $ 29.2 B | ||
|
Danaher Corporation
DHR
|
145 B | $ 195.65 | 2.23 % | $ 139 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
15.3 B | $ 121.72 | 2.04 % | $ 19.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 198.39 | -0.28 % | $ 22 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
45.8 B | $ 113.9 | 1.85 % | $ 34.6 B | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.12 | 0.91 % | $ 1.42 M | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 9.28 | 10.24 % | $ 263 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.39 | 1.76 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.45 | 3.73 % | $ 2.05 B | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 78.83 | 0.41 % | $ 5.32 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.41 | 3.68 % | $ 423 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 458.61 | 1.1 % | $ 13.2 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 220.43 | 1.77 % | $ 25.2 B | ||
|
Celcuity
CELC
|
506 M | $ 115.07 | 0.15 % | $ 4.54 B | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
432 M | $ 18.31 | 5.23 % | $ 410 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
5.53 B | $ 201.15 | 1.76 % | $ 19.8 B | ||
|
OPKO Health
OPK
|
1.62 B | $ 1.2 | 0.84 % | $ 833 M |